Moreover, these results confirm Wang et al.’s hypothesis (Wang et al., 2018) that lowering MCP-1 level might confer an associated clinical progress in ICU patients with major trauma as decreasing MCP-1 level was accompanied by a significant reduction in incidence of sepsis development. This evidence concerns the gene CCL2 and Sepsis.